跳转至内容
Merck
CN

Meet us at the 17th World ADC San Diego, October 12-15, 2026, and explore our specialized solutions designed to safeguard your ADC journey. Whether you are considering outsourcing to a CDMO or looking to enhance your in-house capabilities, stop by booth #71 and 72, where our experts will guide you through: 

  • Our comprehensive CDMO services for ADCs and bioconjugates
  • And our latest bioprocessing product innovations for safe and efficient purification.

Immerse yourself in Booth #71 and 72

  • Meet our experts to discuss how we can meet the specific needs of your ADC and Bioconjugation program as your flexible CDMO, and to learn more about our capacity investment and expanded mAb intermediate and fill-finish capabilities.
  • Learn how our BioReliance® testing services can help derisk your ADC development with tailored analytical development, comprehensive testing, regulatory expertise, and validated methods.
  • Discover the new Mobius® TFF 20 Single-use System, specifically designed for efficient concentration and diafiltration of proteins. Learn how this new system can help reduce contamination risks and protect operators through its closed mode of operation.
  • Learn more about the Mobius® ADC Reactor, a scalable family of single-use mixing systems perfected for bioconjugation.
  • Find out how Pellicon® Capsules, a single-use TFF device optimized for the efficient concentration and purification of ADCs, helps reduce contamination risks while increasing operator safety.

Attend Our Talks:

Evaluating Characterization of a Purpose-Built Single-Use ADC Conjugation Reactor: Scalability, Material Compatibility & Operational Performance

Maria Mora, Bioprocessing Engineer

  • Assessing the Mobius® ADC Reactor as a single-use system developed specifically for ADC conjugation workflows
  • Characterizing mixing time and temperature control across 10L to 500L reactor scales, contextualized with a case study preserving ADC CQAs
  • Evaluating wetted materials for tensile strength retention and extractables following exposure to 100% DMSO and DMAc via RP-HPLC and DI-GC/MS to establish a leachable dataset relevant to ADC impurity control strategies

Date: October 12, 2026
Time: 12:30 

Enhanced ADC Development Through Integrated Chemistry & Technology

Lisa McDermott, Director, Process & Analytical Development

  • Discussing an integrated platform approach that utilizes real-time PAT, engineering principles, and strategic methodologies
  • Outlining strategies for optimizing conjugation chemistry and dual payload conjugates
  • Exploring case studies to demonstrate how this approach enhances decision making, reduces timelines, and improves cost efficiencies in the ADC pipeline

Date: October 13, 2026
Time: 12:30

Register now:  17th World ADC San Diego | October 12-15, 2026


Related webinars

Manufacturing operator in full protective clothing, concentrating carefully while working on conjugating drug linkers in a clean, high-tech facility.
Demonstrating Technical Excellence in Contract Manufacturing

Explore in(on)line testing for conjugation process, get insights of PATs at different steps and share advancements through case studies for real-time monitoring the reduction and conjugation process by online HPLC.

Manufacturing operator in full protective clothing, concentrating carefully while working on conjugating drug linkers in a clean, high-tech facility.
PAT Implementation for ADC & Bioconjugation Processes: Applications and Case Studies

Get insights on successfully scaling up from PAD to manufacturing, leveraging an integrated linker-payload supply chain, and implementing Process Analytical Technology (PAT)

Manufacturing operator in full protective clothing, concentrating carefully while working on conjugating drug linkers in a clean, high-tech facility.
Leveraging Single-Use Technologies for ADC Manufacturing

Explore single-use technologies in ADC manufacturing, and gain insights into key data, design considerations, and operational advantages.